Institution record
Narkasa
- Source score
- 1.0
- Warnings
- 0
- Comments
- 0
Licence records
Licences within our coverage (global foreign exchange, cfd and currency-pair dealers outside regional registers) are listed first. Check each one on the regulator's own register.
| Regulator | Licence no. | Status | Licensed entity | Date | |
|---|---|---|---|---|---|
Financial Crimes Investigation Board of Türkiye (MASAK) | Not supplied | Revoked | Narkasa Yazılım Ticaret Anonim Şirketi | 2021 |
Peer regulatory & risk comparison
Side-by-side supervisory and risk benchmark comparing Narkasa against peer institutions in our global foreign exchange, cfd and currency-pair dealers outside regional registers dataset.
| Institution | Primary regulators | Regulated / total | Risk classification | Source score | Warnings |
|---|---|---|---|---|---|
| Narkasa (this record) | Financial Crimes Investigation Board of Türkiye (MASAK) | 0 / 1 | Risk level not supplied | 1.0 | 0 |
| CXM | FSCA | 1 / 1 | Risk level not supplied | 6.1 | 0 |
| FTM Brokers | NBRB | 1 / 1 | Risk level not supplied | 6.0 | 0 |
| MEKSA | CMB | 1 / 1 | Risk level not supplied | 6.0 | 0 |
| İntegral Yatırım | CMB | 1 / 1 | Risk level not supplied | 5.0 | 0 |
| OpenFX | NBRB | 1 / 1 | Risk level not supplied | 5.0 | 0 |
Narkasa: institutional due diligence FAQ
Key supervisory, licensing, and counterparty verification questions generated from the dataset.
What is Narkasa's regulatory licence status and supervisory authorisation?
In our imported dataset, Narkasa (legal entity reference: Narkasa) holds 1 recorded licence entry, of which 0 carry a "regulated" status and 0 are marked regulated or registered: Financial Crimes Investigation Board of Türkiye (MASAK) — licence Not supplied, status: revoked. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official Financial Crimes Investigation Board of Türkiye (MASAK) public register.
Which of Narkasa's jurisdictions and licences fall within this site's regulatory coverage?
Narkasa is registered at Maslak Mahallesi, Büyükdere Cd. No:255, 34485 Sarıyer/İstanbul, Türkiye and tracked under our global foreign exchange, cfd and currency-pair dealers outside regional registers scope based on its institutional service profile (Crypto spot trading, Derivatives contracts, Investment products) rather than a domestic focus licence. Its 1 recorded licence (Financial Crimes Investigation Board of Türkiye (MASAK)) should be evaluated for cross-border passporting and local solicitation rules.
What is Narkasa's institutional risk classification, enforcement exposure, and score profile?
Narkasa carries a "risk level not supplied" classification in the source dataset, alongside composite 5-dimension ratings out of 10 (overall: 1.0, risk & licensing: 1.0, brand: 1.0, market influence: 1.0, user reputation: 0.0). The record flags 0 regulatory warning or complaint counts and 1 licence record with elevated status flags (Financial Crimes Investigation Board of Türkiye (MASAK): revoked). Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.
What operational due diligence steps apply to Narkasa's platforms, entity structure, and complaints?
Before allocating capital or executing trades with Narkasa (listed execution software: Narkasa), institutional and retail allocators should: (1) confirm the domain (narkasa.com) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to Financial Crimes Investigation Board of Türkiye (MASAK).
Related institutional research & regulatory analysis
Editorial briefings and compliance research from FXOpen Ledger relevant to Narkasa's supervisory scope.
prime-liquidity
OTC FX Prime-of-Prime Liquidity & Last-Look Execution Book: 2026 Definitive Institutional Guide, Quantitative Benchmarks & Regulatory Audit
Definitive 2026 flagship cornerstone guide to OTC FX Prime-of-Prime Liquidity & Last-Look Execution Book on OpenFX Book (fxopenledger.com). Covers BIS / Global FX Committee (FX Global Code) / CLS Bank statutory rules, Tier-1 quantitative benchmarks, mathematical formulation (FX-POP-ORDERBOOK), and compliance verification.
OTC FX Microstructure
OTC FX Last-Look Symmetry Audit — Desk Benchmark Methodology: 2026 Institutional Audit & Desk Controls
2026 institutional desk audit of otc fx last-look symmetry audit focusing on desk benchmark methodology. Covers statutory register tie-out (CLS-PVP), 10.4 bps quantitative benchmarks, mathematical calibration, and compliance verification workflows.
Dealer Execution
OTC FX Last-Look Symmetry Audit — Regulatory Filing Cross-Check: 2026 Institutional Audit & Desk Controls
2026 institutional desk audit of otc fx last-look symmetry audit focusing on regulatory filing cross-check. Covers statutory register tie-out (WMR-4PM), 4.0 bps quantitative benchmarks, mathematical calibration, and compliance verification workflows.
Prime & Margin Conduits
ISDA 2002 Master Agreement & VM-CSA Operational Mechanics: Valuation Percentages, Minimum Transfer Amounts, and Dispute Resolution
Structuring Minimum Transfer Amounts (MTA), Independent Amounts (IA), and eligible collateral valuation haircuts for institutional OTC FX portfolios.